Twist Bioscience Corporation (TWST)

NASDAQ: TWST · IEX Real-Time Price · USD

47.32

-1.61 (-3.29%)

At close: Jul 2, 2024, 4:00 PM

47.90

+0.58 (1.23%)

After-hours: Jul 2, 2024, 7:38 PM EDT

Twist Bioscience Cash Flow Statement

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Year	2023	2022	2021	2020	2019	2018 - 2016
Net Income	-204.62	-217.86	-152.1	-139.93	-107.67	Upgrade
Depreciation & Amortization	31.88	36.64	11.99	5.63	6.11	Upgrade
Share-Based Compensation	30.28	79.66	37	17.1	11.17	Upgrade
Other Operating Activities	-0.02	-22.83	-9.14	-25.05	2.45	Upgrade
Operating Cash Flow	-142.47	-124.39	-112.24	-142.26	-87.94	Upgrade
Capital Expenditures	-27.78	-101.86	-27.06	-9.87	-14.74	Upgrade
Acquisitions	0	-13.92	-0.48	0	0	Upgrade
Change in Investments	78.39	-117.16	183.7	-104.78	-90.07	Upgrade
Investing Cash Flow	50.61	-232.93	156.16	-114.65	-104.81	Upgrade
Share Issuance / Repurchase	5.32	279.85	343.36	309.49	161.08	Upgrade
Debt Issued / Paid	0	-1.56	-3.33	-3.33	-2.5	Upgrade
Other Financing Activities	-4.41	-7.75	-10.85	-2.42	-	Upgrade
Financing Cash Flow	0.91	270.53	329.18	303.73	158.58	Upgrade
Exchange Rate Effect	-0.03	-0.32	0.02	0.02	0.03	Upgrade
Net Cash Flow	-90.98	-87.1	373.11	46.85	-34.14	Upgrade
Free Cash Flow	-170.25	-226.24	-139.31	-152.12	-102.67	Upgrade
Free Cash Flow Margin	-69.46%	-111.14%	-105.27%	-168.84%	-188.79%	Upgrade
Free Cash Flow Per Share	-2.99	-4.20	-2.89	-3.88	-3.74	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).